semaglutide type 2 diabetes lifestyle changes Is Right for You? Exploring the Benefits and Risks The role of weight control

Safety, Monitoring, and Patient Selection Who Is the Ideal Candidate The ideal candidate for this therapy is an adult over the age of 30 experiencing the clinical signs of somatopausedecreased energy, poor sleep, increased visceral adiposity, and delayed recovery

Two are FDA-approved specifically as injectable weight loss medications: Saxenda (liraglutide) approved in 2014, injected once daily

Mol Cell Endocrinol 248 , 182191 (2006)

To view a copy of this license, visit About this article Cite this article Song, X., Jia, H., Jiang, Y

But the Wegovy dosing demonstrates even more metabolic health benefits and weight loss than previous doses